Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

MAvERIC-Pilot is a Phase II Study in Recurrent Pericarditis and is Anticipated…

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Toronto, Ontario–(Newsfile Corp. – November 16, 2023) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis

Toronto, Ontario–(Newsfile Corp. – November 1, 2023) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Endexx Shareholder Update Highlights Projected Momentum and Growth Rate for 2024

HYLA Targets 300% Compound Growth Rate per Year for the Next 3-5…

Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease

VANCOUVER, British Columbia, September 27, 2023–(BUSINESS WIRE)–Alpha Cognition Inc. (CSE: ACOG) (OTCQB:…

Vinergy Provides Update on Healthcare AI Investments and Highlights from New Investor Presentation

VANCOUVER, BC / ACCESSWIRE / September 27, 2023 / Vinergy Capital Inc. (the…

Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%

Endexx Year Over Year Six Month Revenues Grew 528% CAVE CREEK, AZ, Sept.…